Back to Search Start Over

A robust CD8

Authors :
Jinteng, Feng
Longwen, Xu
Shirong, Zhang
Luying, Geng
Tian, Zhang
Yang, Yu
Rui, Yuan
Yusheng, He
Zhuhui, Nan
Min, Lin
Hui, Guo
Source :
Frontiers in immunology. 13
Publication Year :
2022

Abstract

Patients with stage III lung adenocarcinoma (LUAD) have significant survival heterogeneity, meanwhile, CD8

Subjects

Subjects :
Lung Neoplasms
Ubiquitin-Protein Ligases
Humans
Adenocarcinoma of Lung
Immunotherapy
Kaplan-Meier Estimate
CD8-Positive T-Lymphocytes
Prognosis

Details

ISSN :
16643224
Volume :
13
Database :
OpenAIRE
Journal :
Frontiers in immunology
Accession number :
edsair.pmid..........80e0f4eaeb218a7a758a1162eea77182

Tools

Authors Abstract Subjects Details